Metrion Biosciences Ltd (“Metrion”), the specialist preclinical contract research organization (CRO) and a leader in ion channel screening, today announced the appointment of Dr Chris Mathes, MBA, as
Disclaimer: All resources on this site are collected from the internet. If any content infringes on your rights, please contact us and we will remove it within 24 hours.
Like 
Dislike